Trump signs trio of AI executive orders
Dive Brief:
President Donald Trump signed a trio of executive orders targeting AI infrastructure, exports and development on Wednesday during a summit in Washington D.C.
The sweeping executive orders aim to, in part, fast-track federal permitting, streamline reviews and expedite construction of major AI infrastructure projects. Increasing AI exports is another focus. The administration also banned the federal government from procuring AI that 'has been infused with partisan bias,' Trump said.
'From this day forward, it will be a policy of the United States to do whatever it takes to lead the world in artificial intelligence,' Trump said during the event. 'America is the country that started the AI race. I'm here today to declare that America is going to win it.'
Dive Insight:
The executive orders come just hours after the administration released its AI Action Plan, which identified 90-plus federal policy actions on infrastructure, innovation, and international diplomacy and security.
'There's a global competition now to lead in artificial intelligence, so we want the United States to win that race,' David Sacks, White House AI and crypto czar, said Wednesday during a press call.
Stemming from an earlier executive order, the AI Action Plan represents the most comprehensive view of the direction of federal AI governance since the president's second term started in January. The plan also symbolizes a sharper shift from Biden-era rules, which Trump rescinded as part of his initial shaping of oversight.
The report outlined a number of policies that would impact enterprises, such as the recommendation to establish regulatory sandboxes around the country for researchers, startups and large organizations to deploy and test AI tools. Another directive included a push for public and private sector stakeholders to accelerate the development and adoption of domain-specific national standards for AI systems.
'The bottleneck to harnessing AI's full potential is not necessarily the availability of models, tools, or applications," the document states. 'Rather, it is the limited and slow adoption of AI, particularly within large, established organizations.'
The plan also seeks to address some of the capacity issues enterprises are facing via streamlined permitting for data centers — along with other measures.
'Although many CIOs want to implement AI within their organizations, there remain significant concerns about whether the systems will be reliable both from a performance and a hallucination perspective,' Ram Bala, associate professor at the Leavey School of Business at Santa Clara University, said in an email. 'Building of data centers addresses the hardware capacity issue and improves operational performance.'
CIOs could also feel more confident embarking on AI journeys given the federal push, Bala said.
Before the action plan and executive orders Wednesday, the president signed a directive around AI training in April and has promoted an AI infrastructure push. The administration has also taken aim at evolving state-level AI laws and spoken out against 'AI doomerism.' A senior White House official confirmed that future moves will align with the action plan.
'Instead of cultivating skepticism, our policy is to encourage and enable AI adoption across government and the private sector,' said Michael Kratsios, assistant to the president and White House Office of Science and Technology policy director, during the Wednesday call.
Responses to the AI action plan have been swift and divided. Leaders from the U.S. Chamber of Commerce and Department of Labor were quick to applaud the report. The Software and Information Industry Association and the Center for Data Innovation also welcomed the plan.
Some groups have criticized the continued push for limiting state laws in the report, which directs the Federal Communications Commission to evaluate whether state AI regulations interfere with the agency's ability to carry out its obligations. The plan also recommends the federal government withhold funding from states with 'burdensome AI regulations.'
'This preemption effort stifles local initiatives to uphold civil rights and shield communities from biased AI systems in areas like employment, education, health care, and policing,' Cody Venzke, senior policy counsel in the American Civil Liberties Union's National Political Advocacy department, said in a statement.
Venzke also spoke out against the report's policy recommendation to revise the National Institute of Standards and Technology AI Risk Management Framework to eliminate references to misinformation, diversity, equity and inclusion and climate change.
The report stops short of addressing AI agents, copyright and intellectual property issues.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
DEA Accountability as Cannabis Research Crisis Deepens And Patients Suffer
With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. MMJ International Holdings Issues Clarification on Irvine Labs. WASHINGTON, DC / / August 1, 2025 / MMJ International Holdings, Inc. ("MMJ") today issued a public clarification regarding prior statements about Irvine Labs, Inc., while calling for an urgent reckoning with the U.S. Drug Enforcement Administration's (DEA) catastrophic mismanagement of America's cannabis research policy. In a previous press release, MMJ referenced widespread inactivity among DEA-registered marijuana manufacturers. While these statements were intended to highlight systemic failures within the DEA's quota and licensing system, MMJ acknowledges that this language may have unintentionally caused confusion regarding Irvine Labs, Inc. MMJ hereby clarifies that Irvine Labs, Inc. is a registered DEA entity and, to the best of MMJ's current knowledge, holds valid DEA registrations. MMJ did not intend to imply that Irvine Labs is inactive or insolvent, and any interpretation suggesting otherwise is hereby retracted. This clarification, however, does not alter the underlying crisis: the DEA's marijuana manufacturing quota system is fundamentally broken. Despite a supposed expansion of DEA licenses, no registrant-except MMJ-has produced sufficient pharmaceutical-grade cannabis to support a single FDA-compliant clinical trial. The Devastating Reality: Maridose (Maine): Only 1,100 sq. ft. of space, not growing. Bright Green Corp: Surrendered its registration without ever planting a crop. Royal Emerald Pharmaceuticals: Inactive and facing financial distress. Groff NA Hemplex & Scottsdale Research Institute: No active cultivation for clinical trials. BRC: Producing quantities far below clinical thresholds. University of Mississippi: Continues to grow substandard, research-incompatible marijuana. MMJ remains the only federally compliant entity actively pursuing the cultivation of strain-specific, pharmaceutical-grade cannabis for FDA-approved clinical trials targeting Huntington's Disease and Multiple Sclerosis. Yet, for over seven years, the DEA has obstructed MMJ's efforts through unconstitutional administrative proceedings, arbitrary quotas, and a bureaucratic "Catch-22" that demands documentation (BFSA) which is unattainable without the very registration the DEA refuses to grant. A Constitutional Crisis Exposed The Supreme Court's rulings in Axon v. FTC and Jarkesy v. SEC have now exposed the DEA's internal administrative law judge (ALJ) system as an unconstitutional charade. Despite this, DEA legal counsel Aarathi Haig continues to defend a system the Department of Justice has now abandoned. Former Chief ALJ John "McLooney" Mulrooney has since retired, leaving behind what critics call a "legal dumpster fire." MMJ's legal exceptions, filed July 3, 2025, detail the agency's structural bias, retroactive sabotage, and deliberate obstruction of medical research. "We followed every law, built the FDA-inspected facility, and secured our clinical approvals," said Duane Boise, CEO of MMJ International Holdings. "What the DEA calls regulation is nothing more than bureaucratic revenge." The Time for Reckoning is Now With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. This demands immediate action: Fire entrenched obstructionists like Thomas Prevoznik. Investigate Aarathi Haig for perpetuating unconstitutional legal processes. Transfer oversight of cannabis research to the FDA, where science-not sabotage-will guide policy. "The DEA has spent a decade fortifying a broken system that protects monopolies, obstructs innovation, and ignores public safety disasters like the Assured Testing Labs scandal in Massachusetts," said Boise. "America doesn't need another anti-marijuana crooner in a suit-it needs a leader who will stand up to this agency's sabotage and put patients first." MMJ International Holdings remains committed to factual accuracy and will continue to expose systemic failures that endanger patients, stifle science, and betray the public trust. MMJ is represented by attorney Megan Sheehan. CONTACT:Madison HiseyMHisey@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
a minute ago
- Yahoo
Trump tariffs: Which Canadian sectors will be hit, and how hard?
The bulk of Canadian trade with the U.S. still falls under the Canada-U.S.-Mexico Free Trade Deal (CUSMA). But President Donald Trump's new tariffs will hit some sectors in Canada hard. Mike Armstrong explains.
Yahoo
a minute ago
- Yahoo
Trump tariffs: What are the sticking points in the Canada-US trade negotiation
Prime Minister Mark Carney has remained tight lipped following U.S. President Donald Trump's announcement he would raise the tariff on Canada from 25 per cent to 35 per cent. His policy, while Canada-U.S. trade talks are ongoing, is not to negotiate in public. Mercedes Stephenson breaks down the major sticking points that could be slowing down the negotiations.